Andrew D Sklawer's most recent trade in Fresh Tracks Therapeutics Inc was a trade of 55,000 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 24, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fresh Tracks Therapeutics Inc | Andrew D. Sklawer | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 55,000 | 55,000 | - | - | Restricted Stock Units | |
| Fresh Tracks Therapeutics Inc | Andrew D. Sklawer | COO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 450,000 | 450,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | Andrew D. Sklawer | COO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | Andrew D. Sklawer | COO and Secretary | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 17 May 2021 | 15,375 | 124,625 (1%) | 0% | 0.8 | 12,300 | Common Stock |